← All organizations

NeuroVia, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 1, 2017

Defunct as of Dec 31, 2020

Timeline

2010s

Jun 1, 2013
NeuroVia, Inc.— Founded

2020s

Dec 31, 2020
NeuroVia, Inc.— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

sobetirome

Indications

Studied for

Adrenoleukodystrophy

Recent trials (2)

NCT03196765Study directorPhase 1/Phase 2Oct 1, 2017
NCT03196765Lead sponsorPhase 1/Phase 2Oct 1, 2017

Details

Founded: San Francisco, CA, US Jun 1, 2013
Last known activity: Oct 1, 2017